Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Universal Health Services Gelecekteki Büyüme
Future kriter kontrolleri 1/6
Universal Health Services kazanç ve gelirin sırasıyla yıllık 9.2% ve 5.8% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 11.8% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 16.1% olacağı tahmin edilmektedir.
Anahtar bilgiler
9.2%
Kazanç büyüme oranı
11.8%
EPS büyüme oranı
Healthcare kazanç büyümesi | 19.3% |
Gelir büyüme oranı | 5.8% |
Gelecekteki özkaynak getirisi | 16.1% |
Analist kapsamı | Good |
Son güncelleme | 09 Sep 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down
Sep 26Universal Health Services: Stock Has Lots Of Upside Runway
Sep 17Investors Aren't Entirely Convinced By Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Aug 10We Think Universal Health Services (NYSE:UHS) Can Stay On Top Of Its Debt
Jul 26Universal Health Services: An Underpriced Healthy Business
Jul 04Is Now The Time To Look At Buying Universal Health Services, Inc. (NYSE:UHS)?
Jun 25Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down
Jun 10This Is Why Universal Health Services, Inc.'s (NYSE:UHS) CEO Compensation Looks Appropriate
May 09Universal Health Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 26Market Cool On Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Apr 17Universal Health Services, Inc. (NYSE:UHS) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 01Is Universal Health Services (NYSE:UHS) Using Too Much Debt?
Feb 20Universal Health Services (NYSE:UHS) Will Want To Turn Around Its Return Trends
Feb 05With Universal Health Services, Inc. (NYSE:UHS) It Looks Like You'll Get What You Pay For
Jan 09Is There An Opportunity With Universal Health Services, Inc.'s (NYSE:UHS) 48% Undervaluation?
Dec 13What Does Universal Health Services, Inc.'s (NYSE:UHS) Share Price Indicate?
Nov 02Capital Allocation Trends At Universal Health Services (NYSE:UHS) Aren't Ideal
Oct 15Universal Health Services (NYSE:UHS) Takes On Some Risk With Its Use Of Debt
Sep 28Universal Health Services: Seeking A Cure For Flat Performance
Sep 11Is Universal Health Services, Inc. (NYSE:UHS) Potentially Undervalued?
Jul 23Universal Health Services: Business Is On The Mend
Jul 12Returns On Capital Signal Tricky Times Ahead For Universal Health Services (NYSE:UHS)
Jul 10Here's Why Universal Health Services (NYSE:UHS) Has A Meaningful Debt Burden
Jun 26Calculating The Fair Value Of Universal Health Services, Inc. (NYSE:UHS)
May 28Should You Think About Buying Universal Health Services, Inc. (NYSE:UHS) Now?
Apr 23Universal Health Services (NYSE:UHS) Could Be Struggling To Allocate Capital
Apr 07Here's Why Universal Health Services (NYSE:UHS) Has A Meaningful Debt Burden
Mar 23Universal Health Services Q4 2022 Earnings Preview
Feb 24Is Universal Health Services, Inc. (NYSE:UHS) Trading At A 31% Discount?
Feb 14Universal Health: Retain Buy As Systematic Defensive Overlay
Feb 04Universal Health Services declares $0.20 dividend
Jan 18Universal Health Services (NYSE:UHS) Will Be Hoping To Turn Its Returns On Capital Around
Jan 05Universal Health Services upgraded at Wells Fargo on improving operating environment
Jan 03Is It Too Late To Consider Buying Universal Health Services, Inc. (NYSE:UHS)?
Dec 21Is Universal Health Services (NYSE:UHS) Using Too Much Debt?
Dec 08Universal Health Services: Attractive Even In Light Of Cost Concerns
Nov 14Is There An Opportunity With Universal Health Services, Inc.'s (NYSE:UHS) 50% Undervaluation?
Nov 10Universal Health net income falls 19% but still good enough for a bottom line beat
Oct 25Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 17,513 | 1,223 | 1,108 | 1,890 | 13 |
12/31/2025 | 16,591 | 1,154 | 871 | 1,740 | 16 |
12/31/2024 | 15,690 | 1,074 | 1,012 | 1,882 | 16 |
6/30/2024 | 15,018 | 934 | 833 | 1,690 | N/A |
3/31/2024 | 14,658 | 816 | 591 | 1,373 | N/A |
12/31/2023 | 14,282 | 717 | 525 | 1,268 | N/A |
9/30/2023 | 14,025 | 676 | 412 | 1,113 | N/A |
6/30/2023 | 13,799 | 692 | 509 | 1,172 | N/A |
3/31/2023 | 13,574 | 684 | 139 | 841 | N/A |
12/31/2022 | 13,399 | 675 | 262 | 996 | N/A |
9/30/2022 | 13,228 | 739 | 261 | 1,021 | N/A |
6/30/2022 | 13,048 | 774 | 482 | 1,242 | N/A |
3/31/2022 | 12,922 | 935 | 469 | 1,257 | N/A |
12/31/2021 | 12,642 | 990 | 48 | 884 | N/A |
9/30/2021 | 12,454 | 1,059 | -124 | 704 | N/A |
6/30/2021 | 12,210 | 1,081 | 170 | 1,028 | N/A |
3/31/2021 | 11,742 | 1,008 | 1,134 | 1,930 | N/A |
12/31/2020 | 11,559 | 941 | 1,626 | 2,360 | N/A |
9/30/2020 | 11,368 | 878 | 1,842 | 2,552 | N/A |
6/30/2020 | 11,278 | 734 | 1,541 | 2,217 | N/A |
3/31/2020 | 11,404 | 721 | 847 | 1,509 | N/A |
12/31/2019 | 11,378 | 813 | 783 | 1,438 | N/A |
9/30/2019 | 11,237 | 726 | 778 | 1,430 | N/A |
6/30/2019 | 11,063 | 801 | 696 | 1,340 | N/A |
3/31/2019 | 10,889 | 789 | 614 | 1,297 | N/A |
12/31/2018 | 10,772 | 779 | 574 | 1,275 | N/A |
9/30/2018 | 10,661 | 840 | 585 | 1,254 | N/A |
6/30/2018 | 10,554 | 810 | 557 | 1,256 | N/A |
3/31/2018 | 10,485 | 770 | N/A | 1,110 | N/A |
12/31/2017 | 10,410 | 752 | N/A | 1,248 | N/A |
9/30/2017 | 10,243 | 707 | N/A | 1,076 | N/A |
6/30/2017 | 10,111 | 717 | N/A | 1,031 | N/A |
3/31/2017 | 9,929 | 717 | N/A | 1,342 | N/A |
12/31/2016 | 9,766 | 702 | N/A | 1,334 | N/A |
9/30/2016 | 9,606 | 702 | N/A | 1,361 | N/A |
6/30/2016 | 9,424 | 700 | N/A | 1,326 | N/A |
3/31/2016 | 9,268 | 697 | N/A | 1,225 | N/A |
12/31/2015 | 9,043 | 680 | N/A | 1,068 | N/A |
9/30/2015 | 8,905 | 679 | N/A | 1,143 | N/A |
6/30/2015 | 8,716 | 612 | N/A | 1,109 | N/A |
3/31/2015 | 8,492 | 581 | N/A | 1,113 | N/A |
12/31/2014 | 8,205 | 545 | N/A | 1,036 | N/A |
9/30/2014 | 7,830 | 497 | N/A | 998 | N/A |
6/30/2014 | 7,607 | 529 | N/A | 952 | N/A |
3/31/2014 | 7,391 | 529 | N/A | 900 | N/A |
12/31/2013 | 7,368 | 510 | N/A | 884 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: UHS 'nin tahmini kazanç büyümesi (yıllık 9.2% ) tasarruf oranının ( 2.5% ) üzerindedir.
Kazançlar ve Piyasa: UHS şirketinin kazançlarının (yıllık 9.2% ) US pazarından (yıllık 15.2% ) daha yavaş büyümesi öngörülüyor.
Yüksek Büyüme Kazançları: UHS şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.
Gelir ve Pazar: UHS şirketinin gelirinin (yıllık 5.8% ) US pazarından (yıllık 8.7% ) daha yavaş büyümesi öngörülüyor.
Yüksek Büyüme Geliri: UHS şirketinin gelirinin (yıllık 5.8% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: UHS 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 16.1 %).